您的位置: 专家智库 > >

国家自然科学基金(30700789)

作品数:2 被引量:1H指数:1
相关作者:刘永芳罗涛毕好生刘志刚徐金金更多>>
相关机构:华中科技大学武汉大学武汉市第一医院更多>>
发文基金:国家自然科学基金更多>>
相关领域:医药卫生更多>>

文献类型

  • 2篇中文期刊文章

领域

  • 2篇医药卫生

主题

  • 1篇蛋白
  • 1篇蛋白激酶
  • 1篇蛋白激酶C
  • 1篇心肌
  • 1篇心肌细胞
  • 1篇血管
  • 1篇血管内皮
  • 1篇血管内皮生长...
  • 1篇血管内皮生长...
  • 1篇异氟醚
  • 1篇细胞
  • 1篇内皮
  • 1篇内皮生长因子
  • 1篇肌细胞
  • 1篇激酶
  • 1篇分泌
  • 1篇分泌血管内皮...
  • 1篇MYOCYT...
  • 1篇RAT
  • 1篇TING

机构

  • 1篇华中科技大学
  • 1篇武汉市第一医...
  • 1篇武汉大学

作者

  • 1篇陈向东
  • 1篇夏中元
  • 1篇徐金金
  • 1篇刘志刚
  • 1篇毕好生
  • 1篇罗涛
  • 1篇刘永芳

传媒

  • 1篇中华麻醉学杂...
  • 1篇Chines...

年份

  • 2篇2010
2 条 记 录,以下是 1-2
排序方式:
蛋白激酶C在异氟醚诱导原代培养大鼠心肌细胞分泌血管内皮生长因子中的作用
2010年
目的 探讨蛋白激酶C(PKC)在异氟醚诱导原代培养大鼠心肌细胞分泌血管内皮生长因子(VEGF)中的作用.方法 1~3 d SD新生大鼠,分离培养原代心肌细胞,随机分为6组(n=6):对照组(C组)培养后的细胞不经任何处理;不同浓度异氟醚组(Ⅰ1组~Ⅰ3组)细胞分别经0.7%、1.4%、2.1%异氟醚处理6 h;PKC抑制剂组(P组)细胞培养液中给予PKC抑制剂--calphostin C,终浓度50 nmol/L;PKC抑制剂+异氟醚组(PI组)心肌细胞培养液中加入calphostin C 50 nmol/L后,置入无菌密闭容器,持续输入1.4%异氟醚6 h.采用ELISA法测定细胞培养液VEGF浓度,Western blot法测定心肌细胞PKC亚型的表达.结果 与C组比较,Ⅰ2组和Ⅰ3组细胞培养液VEGF浓度升高,Ⅰ2组胞浆PKCε表达下调,胞膜PKCε表达上调(P<0.01),胞浆和胞膜PKCα、PKCδ和PKCζ表达差异无统计学意义(P>0.05),P组上述指标差异无统计学意义(P>0.05).与胞膜比较,C组和Ⅰ2组胞浆PKCα、PKCδ和PKCζ表达上调(P<0.05).随异氟醚浓度升高细胞培养液VEGF浓度升高(P<0.05).与Ⅰ2组比较,PI组细胞培养液VEGF浓度降低(P<0.05).结论 异氟醚可通过PKCε从胞浆转位到胞膜的途径诱导心肌细胞分泌VEGF,是异氟醚心肌保护作用的机制之一.
刘志刚罗涛刘永芳徐金金陈向东夏中元毕好生
关键词:异氟醚蛋白激酶C血管内皮生长因子类
Isoflurane induces expression of vascular endothelial growth factor through activating protein kinase C in myocardial cells被引量:1
2010年
Objective: Vascular endothelial growth factor (VEGF) plays important roles in establishing collateral circulation of ischemic myocardium. This study aimed to investigate the effect of isoflurane on VEGF expression and the potential intracellular signal transduction pathway in cultured rat myocardial cells in order to further reveal the molecular mechanism of myocardial preservation of isoflurane. Methods: Primary myocardial cells of Sprague-Dawley rats were isolated and cultured. They were divided randomly into control group, isoflurane group, protein kinase C (PKC) inhibitor group and PKC inhibitor+isoflurane group where cells were respectively incubated without any treatment, treated by 0.5, 1.0 and 1.5 minimum alveolar concentration (MAC) of isoflurane for 6 hours, by PKC inhibitor calphostin C at a final concentration of 50 nmol/L and by 50 nmol/L calphosfin C+ 1.0 MAC isoflurane for 6 hours. VEGF expression was detected by enzyme-linked immunosorbent assay (ELISA) and the expression levels of PKC isoforms were determined by Western immunoblotting method. Results: Isoflurane increased the VEGF expression in myocardial cells in a dose-dependent way. VEGF levels were significantly higher in 1.0 and 1.5 MAC isoflurane groups than in the control group (both P〈0.01). The effect of isoflurane on upregulating VEGF expression was blocked by PKC inhibitor calphostin C (P〈0.01), but calphostin C did not alter VEGF expression (P〉0.05). Isoflurane induced the activation and translocation of PKC Immunoblotting analysis revealed that the immunoreactivity of PKC ε increased significantly in the membrane fractions and deceased significantly in the kytoplasm fractions for cells treated with 1.0 MAC isoflurane as compared with the untreated cells, but not of PKC a, PKCα and PKCζ (P〈0.01). Conclusion: Isoflurane induces myocardial cells to release VEGF through activating PKCε from the endochylema to the cytomembrane, suggesting a possible novel mechanism of isoflurane p
刘志刚夏中元陈向东罗涛
关键词:ISOFLURANE
共1页<1>
聚类工具0